Global Animal Pain Management Market

Animal Pain Management Comprehensive Study by Application (Veterinary Care Center, Veterinary Hospital), Analgesics (Non-opioids, Opioids), Cause (Osteoarthritis, Cancer, Back Pain, Others), End User (Pets, Livestock Animal, Marine Animal) Players and Region - Global Market Outlook to 2030

Animal Pain Management Market by XX Submarkets | Forecast Years 2024-2030  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Animal Pain Management
The global animal pain management market is expected to witness the growth throughout the forecasted period due to the rising swelling pain in animals due to osteoarthritis and growing pain related disorders in pet animals. Animal pain management deals with the pain which is an unpleasant sensory and emotional experience of the animal where it is associated with the inflammation. The pain in animals is even more difficult to quantify and qualify, to manage the pain number of pain-relieving drugs and therapies are used in pets and other animals.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)


There are various companies are exploring the market in new geographical regions by adopting various market growth strategies such as mergers & acquisitions, expansions, investments, new product launches and many others. The market leading players are exploring new opportunity areas through expansions and acquisitions across the globe to avail competitive advantage through combined synergies. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Boehringer Ingelheim (Germany), Merck Animal (United States), Elanco Animal Health (United States), Bayer Animal Health (Germany), Zoetis Inc. (United States), Virbac (France), Ceva Sante Animale (France) and Vetoquinol S.A. (France) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research coverage are Bimeda, Inc. (Ireland), Chanelle Pharma Group (Ireland) and Others.

Segmentation Overview
AMA Research has segmented the market of Global Animal Pain Management market by , Application (Veterinary Care Center and Veterinary Hospital) and Region.



On the basis of geography, the market of Animal Pain Management has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Analgesics, the sub-segment i.e. Non-opioids will boost the Animal Pain Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Cause, the sub-segment i.e. Osteoarthritis will boost the Animal Pain Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Pets will boost the Animal Pain Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Advances in Animal Pain Management Technology and RIsing Animal Pain Management Hospitals and Centers

Market Growth Drivers:
Growing Pain Related Disorders in Pet Animals and Rise in Swelling in Animals Associated with Osteoarthritis

Challenges:
Stringent Regulatory Guidelines on Animal Pain Management

Restraints:
Overdose of Analgesics in Animal for Pain Management Might Effects the Animal Health Adversely

Opportunities:
Increasing Number of Certified Animal Pain Management Professionals and Continuous Research and Development in Animal Pain Management

Market Leaders and their expansionary development strategies
In February 2020, Zoetis Inc. acquired Ethos Diagnostic Science, which is a U.S.-based veterinary reference laboratory for USD 490 million.
In April 2019, Elanco Animal Health announced an agreement to acquire Aratana Therapeutics a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, and developer of the first-of-its-kind canine NSAID for osteoarthritis, Gallipran. Elanco has also signed a development and commercialization agreement with VetDC for Tanovea-CA1, the first U.S. Food and Drug Administration (FDA) conditionally approved canine lymphoma treatment.
"FDA has approved several nonsteroidal anti-inflammatory drugs for dogs to control pain and inflammation associated with osteoarthritis, and to control pain and inflammation after soft tissue and orthopedic surgery. [Orthopedic pertains to bones and muscles; soft tissue is everything else. Repairing a dog’s torn ACL (anterior cruciate ligament) in her knee is an orthopedic surgery; removing a ball from a dog’s stomach is a soft tissue surgery.] The labels for an FDA-approved NSAID for dogs or cats is written specifically for that species. The label includes all the information veterinarians need to use the drug safely and effectively in that species."

Key Target Audience
Animal Pain Management Service Providers, Animal Pain Management Hospitals, Animal Pain Management Industry Associations, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Veterinary Care Center
  • Veterinary Hospital
By Analgesics
  • Non-opioids
  • Opioids

By Cause
  • Osteoarthritis
  • Cancer
  • Back Pain
  • Others

By End User
  • Pets
  • Livestock Animal
  • Marine Animal

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Pain Related Disorders in Pet Animals
      • 3.2.2. Rise in Swelling in Animals Associated with Osteoarthritis
    • 3.3. Market Challenges
      • 3.3.1. Stringent Regulatory Guidelines on Animal Pain Management
    • 3.4. Market Trends
      • 3.4.1. Advances in Animal Pain Management Technology
      • 3.4.2. RIsing Animal Pain Management Hospitals and Centers
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Animal Pain Management, by Application, Analgesics, Cause, End User and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Animal Pain Management (Value)
      • 5.2.1. Global Animal Pain Management by: Application (Value)
        • 5.2.1.1. Veterinary Care Center
        • 5.2.1.2. Veterinary Hospital
      • 5.2.2. Global Animal Pain Management by: Analgesics (Value)
        • 5.2.2.1. Non-opioids
        • 5.2.2.2. Opioids
      • 5.2.3. Global Animal Pain Management by: Cause (Value)
        • 5.2.3.1. Osteoarthritis
        • 5.2.3.2. Cancer
        • 5.2.3.3. Back Pain
        • 5.2.3.4. Others
      • 5.2.4. Global Animal Pain Management by: End User (Value)
        • 5.2.4.1. Pets
        • 5.2.4.2. Livestock Animal
        • 5.2.4.3. Marine Animal
      • 5.2.5. Global Animal Pain Management Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
  • 6. Animal Pain Management: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Boehringer Ingelheim (Germany)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Merck Animal (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Elanco Animal Health (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Bayer Animal Health (Germany)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Zoetis Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Virbac (France)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Ceva Sante Animale (France)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Vetoquinol S.A. (France)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Animal Pain Management Sale, by Application, Analgesics, Cause, End User and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Animal Pain Management (Value)
      • 7.2.1. Global Animal Pain Management by: Application (Value)
        • 7.2.1.1. Veterinary Care Center
        • 7.2.1.2. Veterinary Hospital
      • 7.2.2. Global Animal Pain Management by: Analgesics (Value)
        • 7.2.2.1. Non-opioids
        • 7.2.2.2. Opioids
      • 7.2.3. Global Animal Pain Management by: Cause (Value)
        • 7.2.3.1. Osteoarthritis
        • 7.2.3.2. Cancer
        • 7.2.3.3. Back Pain
        • 7.2.3.4. Others
      • 7.2.4. Global Animal Pain Management by: End User (Value)
        • 7.2.4.1. Pets
        • 7.2.4.2. Livestock Animal
        • 7.2.4.3. Marine Animal
      • 7.2.5. Global Animal Pain Management Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Animal Pain Management: by Application(USD Million)
  • Table 2. Animal Pain Management Veterinary Care Center , by Region USD Million (2018-2023)
  • Table 3. Animal Pain Management Veterinary Hospital , by Region USD Million (2018-2023)
  • Table 4. Animal Pain Management: by Analgesics(USD Million)
  • Table 5. Animal Pain Management Non-opioids , by Region USD Million (2018-2023)
  • Table 6. Animal Pain Management Opioids , by Region USD Million (2018-2023)
  • Table 7. Animal Pain Management: by Cause(USD Million)
  • Table 8. Animal Pain Management Osteoarthritis , by Region USD Million (2018-2023)
  • Table 9. Animal Pain Management Cancer , by Region USD Million (2018-2023)
  • Table 10. Animal Pain Management Back Pain , by Region USD Million (2018-2023)
  • Table 11. Animal Pain Management Others , by Region USD Million (2018-2023)
  • Table 12. Animal Pain Management: by End User(USD Million)
  • Table 13. Animal Pain Management Pets , by Region USD Million (2018-2023)
  • Table 14. Animal Pain Management Livestock Animal , by Region USD Million (2018-2023)
  • Table 15. Animal Pain Management Marine Animal , by Region USD Million (2018-2023)
  • Table 16. South America Animal Pain Management, by Country USD Million (2018-2023)
  • Table 17. South America Animal Pain Management, by Application USD Million (2018-2023)
  • Table 18. South America Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 19. South America Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 20. South America Animal Pain Management, by End User USD Million (2018-2023)
  • Table 21. Brazil Animal Pain Management, by Application USD Million (2018-2023)
  • Table 22. Brazil Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 23. Brazil Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 24. Brazil Animal Pain Management, by End User USD Million (2018-2023)
  • Table 25. Argentina Animal Pain Management, by Application USD Million (2018-2023)
  • Table 26. Argentina Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 27. Argentina Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 28. Argentina Animal Pain Management, by End User USD Million (2018-2023)
  • Table 29. Rest of South America Animal Pain Management, by Application USD Million (2018-2023)
  • Table 30. Rest of South America Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 31. Rest of South America Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 32. Rest of South America Animal Pain Management, by End User USD Million (2018-2023)
  • Table 33. Asia Pacific Animal Pain Management, by Country USD Million (2018-2023)
  • Table 34. Asia Pacific Animal Pain Management, by Application USD Million (2018-2023)
  • Table 35. Asia Pacific Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 36. Asia Pacific Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 37. Asia Pacific Animal Pain Management, by End User USD Million (2018-2023)
  • Table 38. China Animal Pain Management, by Application USD Million (2018-2023)
  • Table 39. China Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 40. China Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 41. China Animal Pain Management, by End User USD Million (2018-2023)
  • Table 42. Japan Animal Pain Management, by Application USD Million (2018-2023)
  • Table 43. Japan Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 44. Japan Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 45. Japan Animal Pain Management, by End User USD Million (2018-2023)
  • Table 46. India Animal Pain Management, by Application USD Million (2018-2023)
  • Table 47. India Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 48. India Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 49. India Animal Pain Management, by End User USD Million (2018-2023)
  • Table 50. South Korea Animal Pain Management, by Application USD Million (2018-2023)
  • Table 51. South Korea Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 52. South Korea Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 53. South Korea Animal Pain Management, by End User USD Million (2018-2023)
  • Table 54. Taiwan Animal Pain Management, by Application USD Million (2018-2023)
  • Table 55. Taiwan Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 56. Taiwan Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 57. Taiwan Animal Pain Management, by End User USD Million (2018-2023)
  • Table 58. Australia Animal Pain Management, by Application USD Million (2018-2023)
  • Table 59. Australia Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 60. Australia Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 61. Australia Animal Pain Management, by End User USD Million (2018-2023)
  • Table 62. Rest of Asia-Pacific Animal Pain Management, by Application USD Million (2018-2023)
  • Table 63. Rest of Asia-Pacific Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 64. Rest of Asia-Pacific Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 65. Rest of Asia-Pacific Animal Pain Management, by End User USD Million (2018-2023)
  • Table 66. Europe Animal Pain Management, by Country USD Million (2018-2023)
  • Table 67. Europe Animal Pain Management, by Application USD Million (2018-2023)
  • Table 68. Europe Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 69. Europe Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 70. Europe Animal Pain Management, by End User USD Million (2018-2023)
  • Table 71. Germany Animal Pain Management, by Application USD Million (2018-2023)
  • Table 72. Germany Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 73. Germany Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 74. Germany Animal Pain Management, by End User USD Million (2018-2023)
  • Table 75. France Animal Pain Management, by Application USD Million (2018-2023)
  • Table 76. France Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 77. France Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 78. France Animal Pain Management, by End User USD Million (2018-2023)
  • Table 79. Italy Animal Pain Management, by Application USD Million (2018-2023)
  • Table 80. Italy Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 81. Italy Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 82. Italy Animal Pain Management, by End User USD Million (2018-2023)
  • Table 83. United Kingdom Animal Pain Management, by Application USD Million (2018-2023)
  • Table 84. United Kingdom Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 85. United Kingdom Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 86. United Kingdom Animal Pain Management, by End User USD Million (2018-2023)
  • Table 87. Netherlands Animal Pain Management, by Application USD Million (2018-2023)
  • Table 88. Netherlands Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 89. Netherlands Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 90. Netherlands Animal Pain Management, by End User USD Million (2018-2023)
  • Table 91. Rest of Europe Animal Pain Management, by Application USD Million (2018-2023)
  • Table 92. Rest of Europe Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 93. Rest of Europe Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 94. Rest of Europe Animal Pain Management, by End User USD Million (2018-2023)
  • Table 95. MEA Animal Pain Management, by Country USD Million (2018-2023)
  • Table 96. MEA Animal Pain Management, by Application USD Million (2018-2023)
  • Table 97. MEA Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 98. MEA Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 99. MEA Animal Pain Management, by End User USD Million (2018-2023)
  • Table 100. Middle East Animal Pain Management, by Application USD Million (2018-2023)
  • Table 101. Middle East Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 102. Middle East Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 103. Middle East Animal Pain Management, by End User USD Million (2018-2023)
  • Table 104. Africa Animal Pain Management, by Application USD Million (2018-2023)
  • Table 105. Africa Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 106. Africa Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 107. Africa Animal Pain Management, by End User USD Million (2018-2023)
  • Table 108. North America Animal Pain Management, by Country USD Million (2018-2023)
  • Table 109. North America Animal Pain Management, by Application USD Million (2018-2023)
  • Table 110. North America Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 111. North America Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 112. North America Animal Pain Management, by End User USD Million (2018-2023)
  • Table 113. United States Animal Pain Management, by Application USD Million (2018-2023)
  • Table 114. United States Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 115. United States Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 116. United States Animal Pain Management, by End User USD Million (2018-2023)
  • Table 117. Canada Animal Pain Management, by Application USD Million (2018-2023)
  • Table 118. Canada Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 119. Canada Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 120. Canada Animal Pain Management, by End User USD Million (2018-2023)
  • Table 121. Mexico Animal Pain Management, by Application USD Million (2018-2023)
  • Table 122. Mexico Animal Pain Management, by Analgesics USD Million (2018-2023)
  • Table 123. Mexico Animal Pain Management, by Cause USD Million (2018-2023)
  • Table 124. Mexico Animal Pain Management, by End User USD Million (2018-2023)
  • Table 125. Company Basic Information, Sales Area and Its Competitors
  • Table 126. Company Basic Information, Sales Area and Its Competitors
  • Table 127. Company Basic Information, Sales Area and Its Competitors
  • Table 128. Company Basic Information, Sales Area and Its Competitors
  • Table 129. Company Basic Information, Sales Area and Its Competitors
  • Table 130. Company Basic Information, Sales Area and Its Competitors
  • Table 131. Company Basic Information, Sales Area and Its Competitors
  • Table 132. Company Basic Information, Sales Area and Its Competitors
  • Table 133. Animal Pain Management: by Application(USD Million)
  • Table 134. Animal Pain Management Veterinary Care Center , by Region USD Million (2025-2030)
  • Table 135. Animal Pain Management Veterinary Hospital , by Region USD Million (2025-2030)
  • Table 136. Animal Pain Management: by Analgesics(USD Million)
  • Table 137. Animal Pain Management Non-opioids , by Region USD Million (2025-2030)
  • Table 138. Animal Pain Management Opioids , by Region USD Million (2025-2030)
  • Table 139. Animal Pain Management: by Cause(USD Million)
  • Table 140. Animal Pain Management Osteoarthritis , by Region USD Million (2025-2030)
  • Table 141. Animal Pain Management Cancer , by Region USD Million (2025-2030)
  • Table 142. Animal Pain Management Back Pain , by Region USD Million (2025-2030)
  • Table 143. Animal Pain Management Others , by Region USD Million (2025-2030)
  • Table 144. Animal Pain Management: by End User(USD Million)
  • Table 145. Animal Pain Management Pets , by Region USD Million (2025-2030)
  • Table 146. Animal Pain Management Livestock Animal , by Region USD Million (2025-2030)
  • Table 147. Animal Pain Management Marine Animal , by Region USD Million (2025-2030)
  • Table 148. South America Animal Pain Management, by Country USD Million (2025-2030)
  • Table 149. South America Animal Pain Management, by Application USD Million (2025-2030)
  • Table 150. South America Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 151. South America Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 152. South America Animal Pain Management, by End User USD Million (2025-2030)
  • Table 153. Brazil Animal Pain Management, by Application USD Million (2025-2030)
  • Table 154. Brazil Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 155. Brazil Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 156. Brazil Animal Pain Management, by End User USD Million (2025-2030)
  • Table 157. Argentina Animal Pain Management, by Application USD Million (2025-2030)
  • Table 158. Argentina Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 159. Argentina Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 160. Argentina Animal Pain Management, by End User USD Million (2025-2030)
  • Table 161. Rest of South America Animal Pain Management, by Application USD Million (2025-2030)
  • Table 162. Rest of South America Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 163. Rest of South America Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 164. Rest of South America Animal Pain Management, by End User USD Million (2025-2030)
  • Table 165. Asia Pacific Animal Pain Management, by Country USD Million (2025-2030)
  • Table 166. Asia Pacific Animal Pain Management, by Application USD Million (2025-2030)
  • Table 167. Asia Pacific Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 168. Asia Pacific Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 169. Asia Pacific Animal Pain Management, by End User USD Million (2025-2030)
  • Table 170. China Animal Pain Management, by Application USD Million (2025-2030)
  • Table 171. China Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 172. China Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 173. China Animal Pain Management, by End User USD Million (2025-2030)
  • Table 174. Japan Animal Pain Management, by Application USD Million (2025-2030)
  • Table 175. Japan Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 176. Japan Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 177. Japan Animal Pain Management, by End User USD Million (2025-2030)
  • Table 178. India Animal Pain Management, by Application USD Million (2025-2030)
  • Table 179. India Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 180. India Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 181. India Animal Pain Management, by End User USD Million (2025-2030)
  • Table 182. South Korea Animal Pain Management, by Application USD Million (2025-2030)
  • Table 183. South Korea Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 184. South Korea Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 185. South Korea Animal Pain Management, by End User USD Million (2025-2030)
  • Table 186. Taiwan Animal Pain Management, by Application USD Million (2025-2030)
  • Table 187. Taiwan Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 188. Taiwan Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 189. Taiwan Animal Pain Management, by End User USD Million (2025-2030)
  • Table 190. Australia Animal Pain Management, by Application USD Million (2025-2030)
  • Table 191. Australia Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 192. Australia Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 193. Australia Animal Pain Management, by End User USD Million (2025-2030)
  • Table 194. Rest of Asia-Pacific Animal Pain Management, by Application USD Million (2025-2030)
  • Table 195. Rest of Asia-Pacific Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 196. Rest of Asia-Pacific Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 197. Rest of Asia-Pacific Animal Pain Management, by End User USD Million (2025-2030)
  • Table 198. Europe Animal Pain Management, by Country USD Million (2025-2030)
  • Table 199. Europe Animal Pain Management, by Application USD Million (2025-2030)
  • Table 200. Europe Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 201. Europe Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 202. Europe Animal Pain Management, by End User USD Million (2025-2030)
  • Table 203. Germany Animal Pain Management, by Application USD Million (2025-2030)
  • Table 204. Germany Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 205. Germany Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 206. Germany Animal Pain Management, by End User USD Million (2025-2030)
  • Table 207. France Animal Pain Management, by Application USD Million (2025-2030)
  • Table 208. France Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 209. France Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 210. France Animal Pain Management, by End User USD Million (2025-2030)
  • Table 211. Italy Animal Pain Management, by Application USD Million (2025-2030)
  • Table 212. Italy Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 213. Italy Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 214. Italy Animal Pain Management, by End User USD Million (2025-2030)
  • Table 215. United Kingdom Animal Pain Management, by Application USD Million (2025-2030)
  • Table 216. United Kingdom Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 217. United Kingdom Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 218. United Kingdom Animal Pain Management, by End User USD Million (2025-2030)
  • Table 219. Netherlands Animal Pain Management, by Application USD Million (2025-2030)
  • Table 220. Netherlands Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 221. Netherlands Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 222. Netherlands Animal Pain Management, by End User USD Million (2025-2030)
  • Table 223. Rest of Europe Animal Pain Management, by Application USD Million (2025-2030)
  • Table 224. Rest of Europe Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 225. Rest of Europe Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 226. Rest of Europe Animal Pain Management, by End User USD Million (2025-2030)
  • Table 227. MEA Animal Pain Management, by Country USD Million (2025-2030)
  • Table 228. MEA Animal Pain Management, by Application USD Million (2025-2030)
  • Table 229. MEA Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 230. MEA Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 231. MEA Animal Pain Management, by End User USD Million (2025-2030)
  • Table 232. Middle East Animal Pain Management, by Application USD Million (2025-2030)
  • Table 233. Middle East Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 234. Middle East Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 235. Middle East Animal Pain Management, by End User USD Million (2025-2030)
  • Table 236. Africa Animal Pain Management, by Application USD Million (2025-2030)
  • Table 237. Africa Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 238. Africa Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 239. Africa Animal Pain Management, by End User USD Million (2025-2030)
  • Table 240. North America Animal Pain Management, by Country USD Million (2025-2030)
  • Table 241. North America Animal Pain Management, by Application USD Million (2025-2030)
  • Table 242. North America Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 243. North America Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 244. North America Animal Pain Management, by End User USD Million (2025-2030)
  • Table 245. United States Animal Pain Management, by Application USD Million (2025-2030)
  • Table 246. United States Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 247. United States Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 248. United States Animal Pain Management, by End User USD Million (2025-2030)
  • Table 249. Canada Animal Pain Management, by Application USD Million (2025-2030)
  • Table 250. Canada Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 251. Canada Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 252. Canada Animal Pain Management, by End User USD Million (2025-2030)
  • Table 253. Mexico Animal Pain Management, by Application USD Million (2025-2030)
  • Table 254. Mexico Animal Pain Management, by Analgesics USD Million (2025-2030)
  • Table 255. Mexico Animal Pain Management, by Cause USD Million (2025-2030)
  • Table 256. Mexico Animal Pain Management, by End User USD Million (2025-2030)
  • Table 257. Research Programs/Design for This Report
  • Table 258. Key Data Information from Secondary Sources
  • Table 259. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Animal Pain Management: by Application USD Million (2018-2023)
  • Figure 5. Global Animal Pain Management: by Analgesics USD Million (2018-2023)
  • Figure 6. Global Animal Pain Management: by Cause USD Million (2018-2023)
  • Figure 7. Global Animal Pain Management: by End User USD Million (2018-2023)
  • Figure 8. South America Animal Pain Management Share (%), by Country
  • Figure 9. Asia Pacific Animal Pain Management Share (%), by Country
  • Figure 10. Europe Animal Pain Management Share (%), by Country
  • Figure 11. MEA Animal Pain Management Share (%), by Country
  • Figure 12. North America Animal Pain Management Share (%), by Country
  • Figure 13. Global Animal Pain Management share by Players 2023 (%)
  • Figure 14. Global Animal Pain Management share by Players (Top 3) 2023(%)
  • Figure 15. Global Animal Pain Management share by Players (Top 5) 2023(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Boehringer Ingelheim (Germany) Revenue, Net Income and Gross profit
  • Figure 18. Boehringer Ingelheim (Germany) Revenue: by Geography 2023
  • Figure 19. Merck Animal (United States) Revenue, Net Income and Gross profit
  • Figure 20. Merck Animal (United States) Revenue: by Geography 2023
  • Figure 21. Elanco Animal Health (United States) Revenue, Net Income and Gross profit
  • Figure 22. Elanco Animal Health (United States) Revenue: by Geography 2023
  • Figure 23. Bayer Animal Health (Germany) Revenue, Net Income and Gross profit
  • Figure 24. Bayer Animal Health (Germany) Revenue: by Geography 2023
  • Figure 25. Zoetis Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 26. Zoetis Inc. (United States) Revenue: by Geography 2023
  • Figure 27. Virbac (France) Revenue, Net Income and Gross profit
  • Figure 28. Virbac (France) Revenue: by Geography 2023
  • Figure 29. Ceva Sante Animale (France) Revenue, Net Income and Gross profit
  • Figure 30. Ceva Sante Animale (France) Revenue: by Geography 2023
  • Figure 31. Vetoquinol S.A. (France) Revenue, Net Income and Gross profit
  • Figure 32. Vetoquinol S.A. (France) Revenue: by Geography 2023
  • Figure 33. Global Animal Pain Management: by Application USD Million (2025-2030)
  • Figure 34. Global Animal Pain Management: by Analgesics USD Million (2025-2030)
  • Figure 35. Global Animal Pain Management: by Cause USD Million (2025-2030)
  • Figure 36. Global Animal Pain Management: by End User USD Million (2025-2030)
  • Figure 37. South America Animal Pain Management Share (%), by Country
  • Figure 38. Asia Pacific Animal Pain Management Share (%), by Country
  • Figure 39. Europe Animal Pain Management Share (%), by Country
  • Figure 40. MEA Animal Pain Management Share (%), by Country
  • Figure 41. North America Animal Pain Management Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Boehringer Ingelheim (Germany)
  • Merck Animal (United States)
  • Elanco Animal Health (United States)
  • Bayer Animal Health (Germany)
  • Zoetis Inc. (United States)
  • Virbac (France)
  • Ceva Sante Animale (France)
  • Vetoquinol S.A. (France)
Additional players considered in the study are as follows:
Bimeda, Inc. (Ireland) , Chanelle Pharma Group (Ireland) , Others
Select User Access Type

Key Highlights of Report


Apr 2024 227 Pages 61 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Animal Pain Management Market Quantitative research analysis
Global Animal Pain Management Market Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Boehringer Ingelheim (Germany), Merck Animal (United States), Elanco Animal Health (United States), Bayer Animal Health (Germany), Zoetis Inc. (United States), Virbac (France), Ceva Sante Animale (France) and Vetoquinol S.A. (France) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Advances in Animal Pain Management Technology " is seen as one of major influencing trends for Animal Pain Management Market during projected period 2023-2030.
The Animal Pain Management market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Animal Pain Management Market Report?

Have a Query? Click Here

Other Related Reports

Hip Splint Comprehensive Study by Type (Soft & Elastic, Hard & Rigid, Hinged), Application (Hospitals, Healthcare Centers, Clinics), Distribution Channel (Online, Offline), End User (Adult, Pediatric...
$ 3500
Dental Liners and Bases Comprehensive Study by Type (Zinc Oxide Eugenol, Glass Ionomer, Resin-modified Glass Ionomers, Others), Application (Hospitals, Dental Clinics, Research & Academic Institutes)...
$ 3450
In Vitro Fertilization Comprehensive Study by Type (Fresh Non-donor, Frozen Non-donor, Fresh Donor, Frozen Donor), End Users (Fertility Clinics, Hospitals, Others), Instrument (Disposable Devices, Cu...
$ 3350
Chorea Treatment Comprehensive Study by Type (Chorea-Acanthocytosis Treatment, Sydenham’s Chorea Treatment), Application (Hospitals, Clinics, Therapy Center, Others), Treatment (Medication, - Fluphen...
$ 3750
Nucleic Acid Testing Comprehensive Study by Type (Nucleic Acid Test Kits, Consumables), Nucleic Acid Test Kits (Ligase Chain Reaction (LCR), Transcription–mediated Amplification (TMA), Polymerase Cha...
$ 3750
Neuroscience Comprehensive Study by Type (Whole Brain Imaging, Neuro-microscopy, Electrophysiology, Neuro-functional analysis, Neuro-proteomic analysis, Neuro-cellular manipulation, Neuro-biochemical...
$ 3750